LC
BIIB icon

Lavaca Capital’s Biogen BIIB Stock Holding History

Lavaca Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Hold
447
– – 0.01% 154
2026
Q1 		$81.9K Hold
447
– – 0.01% 137
2025
Q4 		$78.7K Hold
447
– – 0.01% 139
2025
Q3 		$62.6K Hold
447
– – 0.01% 149
2025
Q2 		$56.1K Buy
447
+162
+57% +$20.2K 0.02% 159
2025
Q1 		$39K Buy
285
+257
+918% +$36.7K 0.02% 169
2024
Q4 		$4.28K Buy
+28
New +$4.72K ﹤0.01% 289
2023
Q4 		– Sell
-1,434
Closed -$369K – 96
2023
Q3 		$369K Sell
1,434
-17
-1% -$4.55K 0.12% 118
2023
Q2 		$413K Buy
1,451
+89
+7% +$26.5K 0.12% 116
2023
Q1 		$379K Sell
1,362
-114
-8% -$31.5K 0.08% 143
2022
Q4 		$409K Sell
1,476
-95
-6% -$26.8K 0.13% 132
2022
Q3 		$418K Sell
1,571
-5
-0.3% -$1.06K 0.15% 106
2022
Q2 		$322K Buy
1,576
+41
+3% +$8.38K 0.05% 139
2022
Q1 		$323K Buy
+1,535
New +$334K 0.03% 161
2019
Q2 		– Sell
-45
Closed -$11K – 120
2019
Q1 		$11K Hold
45
– – 0.01% 260
2018
Q4 		$14K Buy
+45
New +$14.4K 0.01% 207

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lavaca Capital's BIIB Position: Q2 2026 in Review

Lavaca Capital held its Biogen (BIIB) position steady in Q2 2026 at 447 shares worth $96.6K. The position accounts for 0.01% of the portfolio, ranked #154.

Lavaca Capital first reported a position in BIIB in Q4 2018 and has held it in 16 quarters since. The position peaked at $418K in Q3 2022. 1,044 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Lavaca Capital held 447 shares of Biogen worth $96.6K as of Q2 2026.
  • Lavaca Capital left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Lavaca Capital's portfolio in Q2 2026, its #154 holding.
  • Lavaca Capital first reported a position in Biogen in Q4 2018 and has held it in 16 quarters since.
  • Lavaca Capital's Biogen position peaked at $418K in Q3 2022.
  • 1,044 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.